Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?

Aaron B KoenigMaria StepanovaSean FelixShirley KalwaneyStephen ClementZobair M Younossi

Published in: Liver international : official journal of the International Association for the Study of the Liver (2016)

Despite recommendations, HAV and HBV vaccination rates in patients with CLD and DM remain relatively low. Better vaccination strategies for these high risk patients should be undertaken.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis b virus
prognostic factors
cardiovascular disease
peritoneal dialysis
glycemic control
insulin resistance
patient reported outcomes
adipose tissue
weight loss
liver failure